Zsírmáj (MASLD/MASH): vizsgálatok itt: Hollandia

In Hollandia 15 Also abroad 367

15 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Where
Amsterdam, Dordrecht, Leiden, Nijmegen, Rotterdam, Tilburg, Utrecht
Életkor
18 év and over
People
1800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632444 · EU 2024-513739-25-00
3. fázisTaking people
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Where
Dordrecht, Leiden, Nijmegen, Rotterdam, Tilburg, Uden, Utrecht
Életkor
18 év and over
People
1590 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00
3. fázisTaking people
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Where
Amsterdam, Rotterdam, Utrecht
Életkor
18 év to 80 év
People
1350 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06318169 · EU 2023-509912-27-00
3. fázisTaking people
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Where
Amsterdam, Rotterdam, Tilburg, Utrecht
Életkor
18 év to 75 év
People
1800 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06419374 · EU 2023-510395-31-00
3. fázisNot yet taking people in Hollandia
A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)
Where
Amsterdam, Rotterdam, Uden
Életkor
18 év and over
People
382 worldwide
Run by
Glaxosmithkline Research & Development Limited
See details and how to join2026-525755-82-00 · EU 2026-525755-82-00
3. fázisNot yet taking people in Hollandia
A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)
Where
Amsterdam, Rotterdam, Uden
Életkor
18 év and over
People
69 worldwide
Run by
Glaxosmithkline Research & Development Limited
See details and how to join2026-525757-37-00 · EU 2026-525757-37-00
3. fázisTaking people
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Where
Amsterdam, Nijmegen, Rotterdam, 's-Hertogenbosch, Utrecht, Zwolle
Életkor
18 év and over
People
4500 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07165028 · EU 2025-522674-36-00
3. fázisTaking people
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Where
Amsterdam, Rotterdam, Uden
Életkor
18 év to 75 év
People
1250 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07221188 · EU 2025-523674-16-00
4. fázisCsak meghívásos
Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)
Where
Rotterdam
Életkor
18 év to 75 év
People
70
Run by
Carmen Dietvorst
See details and how to joinNCT06845345 · EU 2024-519774-40-00
No phaseTaking people
Hepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric Surgery
Where
Amsterdam
Életkor
35 év to 65 év
People
40
Run by
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT07326865
No phaseTaking people
Global Research Initiative for Patients Screening on MASH
Where
Amsterdam, Rotterdam
Életkor
18 év to 75 év
People
10 000 worldwide
Run by
Julius Clinical
See details and how to joinNCT05651724
No phaseTaking people
Effect of Timed-Restricted Eating on Metabolic Health
Where
Amsterdam
Életkor
50 év to 75 év
People
30
Run by
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT06061042
No phaseTaking people
The European NAFLD Registry
Where
Amsterdam
Életkor
18 év to 100 év
People
10 000 worldwide
Run by
Newcastle University
See details and how to joinNCT04442334
No phaseTaking people
European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)
Where
Maastricht
Életkor
Up to 18 év
People
2000 worldwide
Run by
Cambridge University Hospitals NHS Foundation Trust
See details and how to joinNCT04190849
No phaseTaking people
Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease
Where
Maastricht
Életkor
18 év to 65 év
People
500
Run by
Maastricht University Medical Center
See details and how to joinNCT02422238